We selected four tumors for that analysis and two of them (PAAD and HNSC) experienced a negative correlation between CDKN2A alteration and CD8 infiltration, while the other two tumors (BLCA and LUSC) did not experience that correlation. This evidence concerns the gene CDKN2A and bladder transitional cell carcinoma.